Lombardia Capital Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$810K Sell
11,665
-3,828
-25% -$265K 0.74% 64
2016
Q4
$1.04M Buy
15,493
+7,441
+92% +$505K 0.11% 97
2016
Q3
$589K Buy
8,052
+2,373
+42% +$168K 0.04% 152
2016
Q2
$390K Sell
5,679
-12,358
-69% -$866K 0.03% 174
2016
Q1
$1.28M Hold
18,037
0.07% 152
2015
Q4
$1.36M Buy
18,037
+299
+2% +$21.6K 0.07% 140
2015
Q3
$1.15M Buy
17,738
+12,124
+216% +$801K 0.06% 144
2015
Q2
$362K Buy
5,614
+34
+0.6% +$2.29K 0.01% 184
2015
Q1
$392K Sell
5,580
-11,008
-66% -$726K 0.01% 200
2014
Q4
$1.08M Sell
16,588
-13,378
-45% -$826K 0.03% 177
2014
Q3
$1.62M Buy
29,966
+7,195
+32% +$391K 0.05% 164
2014
Q2
$1.22M Hold
22,771
0.03% 172
2014
Q1
$1.09M Hold
22,771
0.03% 181
2013
Q4
$1.09M Buy
22,771
+15,050
+195% +$688K 0.03% 176
2013
Q3
$332K Hold
7,721
0.01% 192
2013
Q2
$331K Buy
+7,721
New +$332K 0.01% 190

Other funds holding STE

Lombardia Capital Partners's STE Position: Q1 2017 in Review

Lombardia Capital Partners reduced its Steris (STE) stake by 25% in Q1 2017, selling an estimated $265K and leaving 11,665 shares worth $810K. The position accounts for 0.74% of the portfolio, ranked #64.

Lombardia Capital Partners first reported a position in STE in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.62M in Q3 2014. 299 funds tracked by Wall St. Rank hold STE as of Q1 2017.

  • Lombardia Capital Partners held 11,665 shares of Steris worth $810K as of Q1 2017.
  • Lombardia Capital Partners sold 3,828 Steris shares in Q1 2017, an estimated $265K.
  • Steris made up 0.74% of Lombardia Capital Partners's portfolio in Q1 2017, its #64 holding.
  • Lombardia Capital Partners first reported a position in Steris in Q2 2013 and has held it in 16 quarters since.
  • Lombardia Capital Partners's Steris position peaked at $1.62M in Q3 2014.
  • 299 funds tracked by Wall St. Rank held Steris as of Q1 2017.

Based on Lombardia Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.